On Sept. 23, the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) approved a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty) in certain populations who have received the first two doses of Pfizer vaccine.On Sept. 23, the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) approved a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty) in certain populations who have received the first two doses of Pfizer vaccine.